Literature DB >> 8769655

Surveillance for Creutzfeldt-Jakob disease--United States.

.   

Abstract

Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE) in cattle are subacute degenerative diseases of the brain classified as transmissible spongiform encephalopathies. BSE was first identified in 1986 in the United Kingdom (UK), where an epizootic involving > 155,000 cattle appeared to have been greatly amplified by exposure of calves to contaminated rendered cattle carcasses in the form of meat and bone meal nutritional supplements. On March 20, 1996, and expert advisory committee to the government of the UK (1995 estimated population: 58.3 million) announced its conclusion that the agent responsible for BSE might have spread to humans, based on recognition of 10 persons with onset of a reportedly new variant form of CJD during February 1994-October 1995. The 10 persons ranged in age from 16 to 39 years (median age at illness onset: 28 years); of the eight persons who had died, five were aged <30 years. In comparison, in the United States, deaths associated with CJD among persons aged <30 years have been extremely rare (median age at death: 68 years). As a result of the newly recognized variant of CJD described in the UK, CDC updated its previous review of national CJD mortality and began conducting active CJD surveillance in five sites in the United States. These reviews did not detect evidence of the occurrence of the newly described variant form of CJD in the United States.

Entities:  

Mesh:

Year:  1996        PMID: 8769655

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Chen Gao; Kang Xiao; Jing Wang; Bao-Yun Zhang; Yuan Wang; Feng Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

3.  Active bacterial core surveillance of the emerging infections program network.

Authors:  A Schuchat; T Hilger; E Zell; M M Farley; A Reingold; L Harrison; L Lefkowitz; R Danila; K Stefonek; N Barrett; D Morse; R Pinner
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

4.  Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.

Authors:  R C Holman; A S Khan; E D Belay; L B Schonberger
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 5.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Disease surveillance and the academic, clinical, and public health communities.

Authors:  Robert W Pinner; Catherine A Rebmann; Anne Schuchat; James M Hughes
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

7.  Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections.

Authors:  Robert W Pinner; Ruth Lynfield; James L Hadler; William Schaffner; Monica M Farley; Mark E Frank; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

8.  Application of the updated CDC isolation guidelines for health care facilities.

Authors:  Shauna Ely Tarrac
Journal:  AORN J       Date:  2008-03       Impact factor: 0.676

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.